Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics

Sophia G. Kisling, Gopalakrishnan Natarajan, Ramesh Pothuraju, Ashu Shah, Surinder K. Batra, Sukhwinder Kaur

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Pancreatic cancer (PC) is a highly lethal malignancy with a 5-year survival rate of 10%. The occurrence of metastasis, among other hallmarks, is the main contributor to its poor prognosis. Consequently, the elucidation of metastatic genes involved in the aggressive nature of the disease and its poor prognosis will result in the development of new treatment modalities for improved management of PC. There is a deep interest in understanding underlying disease pathology, identifying key prognostic genes, and genes associated with metastasis. Computational approaches, which have become increasingly relevant over the last decade, are commonly used to explore such interests. This review aims to address global studies that have employed global approaches to identify prognostic and metastatic genes, while highlighting their methods and limitations. A panel of 48 prognostic genes were identified across these studies, but only five, including ANLN, ARNTL2, PLAU, TOP2A, and VCAN, were validated in multiple studies and associated with metastasis. Their association with metastasis has been further explored here, and the implications of these genes in the metastatic cascade have been interpreted.

Original languageEnglish (US)
Pages (from-to)721-738
Number of pages18
JournalCancer and Metastasis Reviews
Issue number3
StatePublished - Sep 2021


  • Metastasis
  • Molecular markers
  • Prognosis
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics'. Together they form a unique fingerprint.

Cite this